Financial results - GENCO PHARMACEUTICALS SRL

Financial Summary - Genco Pharmaceuticals Srl
Unique identification code: 37197905
Registration number: J2017003242409
Nace: 4646
Sales - Ron
4.858.484
Net Profit - Ron
179.875
Employees
5
Open Account
Company Genco Pharmaceuticals Srl with Fiscal Code 37197905 recorded a turnover of 2024 of 4.858.484, with a net profit of 179.875 and having an average number of employees of 5. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Genco Pharmaceuticals Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - 0 484.880 800.079 1.493.883 2.309.710 3.747.375 4.110.110 4.858.484
Total Income - EUR - - 1 486.014 800.360 1.494.288 2.309.913 3.751.044 4.114.507 4.863.194
Total Expenses - EUR - - 26.363 493.176 729.830 1.336.137 2.049.914 3.281.763 3.760.731 4.657.307
Gross Profit/Loss - EUR - - -26.362 -7.162 70.531 158.151 259.999 469.282 353.776 205.887
Net Profit/Loss - EUR - - -26.362 -7.912 58.960 135.753 226.266 410.920 310.189 179.875
Employees - - 1 2 2 2 2 4 5 5
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 18.9%, from 4.110.110 euro in the year 2023, to 4.858.484 euro in 2024. The Net Profit decreased by -128.581 euro, from 310.189 euro in 2023, to 179.875 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Genco Pharmaceuticals Srl

Rating financiar

Financial Rating -
GENCO PHARMACEUTICALS SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Genco Pharmaceuticals Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Genco Pharmaceuticals Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Genco Pharmaceuticals Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Genco Pharmaceuticals Srl - CUI 37197905

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - 9.302 2.195 25.732 26.631 21.657 52.370 34.150 18.791
Current Assets - - 3.671 88.963 251.864 657.572 662.531 981.431 1.751.981 1.783.129
Inventories - - 0 3.528 219.551 312.272 329.983 438.990 832.161 780.635
Receivables - - 1.541 6.601 9.282 206.416 320.623 513.880 918.433 980.442
Cash - - 2.131 78.834 23.031 138.885 11.925 28.561 1.387 22.053
Shareholders Funds - - -16.511 -24.120 35.308 170.391 368.106 647.745 955.970 1.021.879
Social Capital - - 9.851 9.670 9.483 9.303 9.097 9.125 9.097 9.046
Debts - - 29.484 115.418 242.411 513.894 330.952 401.415 853.704 802.311
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 1.783.129 euro in 2024 which includes Inventories of 780.635 euro, Receivables of 980.442 euro and cash availability of 22.053 euro.
The company's Equity was valued at 1.021.879 euro, while total Liabilities amounted to 802.311 euro. Equity increased by 71.252 euro, from 955.970 euro in 2023, to 1.021.879 in 2024.

Risk Reports Prices

Reviews - Genco Pharmaceuticals Srl

Comments - Genco Pharmaceuticals Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.